Bausch & Lomb (BLCO) Assets Average (2022 - 2026)
Bausch & Lomb's (BLCO) quarterly Assets Average came in at $13.8 billion in Q2 2026, up 1.39% on a YoY basis from $13.6 billion in Q2 2025, and down 0.59% quarter-over-quarter from $13.9 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Assets Average (2022 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Assets Average for 5 consecutive years, with $13.8 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average rose 1.39% year-over-year to $13.8 billion; the trailing twelve-month figure through Jun 2026 stood at $13.8 billion (up 1.39% YoY), and the FY2025 full-year result was $13.7 billion, up 2.16% from the prior year.
- Assets Average eased to $13.8 billion in Q2 2026 per BLCO's latest filing, from $13.9 billion in the prior quarter.
- Across five years, Assets Average topped out at $13.9 billion in Q4 2025 and bottomed at $10.8 billion in Q3 2022.
- Historically, Assets Average has averaged $12.6 billion across 5 years, with a median of $13.3 billion in 2024.
- The sharpest annual moves came in 2023 and 2025: Assets Average increased 21.38% in 2023, then increased 0.61% in 2025.
- Over 5 years, Assets Average stood at $10.9 billion in 2022, then climbed by 21.38% to $13.3 billion in 2023, then advanced by 1.79% to $13.5 billion in 2024, then climbed by 3.22% to $13.9 billion in 2025, then dropped by 0.77% to $13.8 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $13.8 billion, $13.9 billion, and $13.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 13.82 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.82 Bn |
| Mar 31, 2026 | 13.90 Bn |
| Dec 31, 2025 | 13.93 Bn |
| Sep 30, 2025 | 13.83 Bn |
| Jun 30, 2025 | 13.63 Bn |
| Mar 31, 2025 | 13.45 Bn |
| Dec 31, 2024 | 13.49 Bn |
| Sep 30, 2024 | 13.38 Bn |
| Jun 30, 2024 | 13.27 Bn |
| Mar 31, 2024 | 13.37 Bn |
| Dec 31, 2023 | 13.26 Bn |
| Sep 30, 2023 | 12.19 Bn |
| Jun 30, 2023 | 11.24 Bn |
| Mar 31, 2023 | 11.16 Bn |
| Dec 31, 2022 | 10.92 Bn |
| Sep 30, 2022 | 10.85 Bn |
| Jun 30, 2022 | 10.95 Bn |
| Mar 31, 2022 | 10.87 Bn |